News -

Medtech - Private Placement of €9,4 Million in ConceptoMed AS

The Board of Directors of ConceptoMed AS announce the private placement of equity in ConceptoMed AS. Following the share issue, the number of Shareholders in the company amounts to 73 (previously 37). Gross proceeds from the private placement amounts to NOK 89.056.000 (approx. 9,4 MEUR), whereof 25,5 MNOK (approx. 2,7 MEUR) were subscribed by existing shareholders.

ConceptoMed AS stands before an exciting international development of the ground breaking Luer-Jack. This private placement will finance the global market introduction and further growth.

The share issue values ConceptoMed AS at NOK 426 Million (approx. €44,2 Million) post money.

Topics

  • Business enterprise

Contacts

Related content

  • LUER-JACK APPROVED FOR SALE & MARKETING IN EUROPE (CE mark)

    LUER-JACK APPROVED FOR SALE & MARKETING IN EUROPE (CE mark) FIRST ORDERS OF LUER-JACK SHIPPING AFTER CE-MARK APPROVAL ConceptoMed today announced that the company has received CE Mark approval for the Luer-Jack® syringe, a new and innovative medical syringe. Luer-Jack® is now ready for the European market and other large markets, where the CE mark allows for market entry.

  • ConceptoMed with Global IPR strategy + Dehns​ Patent and Trade Mark Attorneys

    Since April 2012, Dehns has drafted and filed over 50 patent applications across 8 families, as well as a number of design registrations and trade marks. Patents have so far been granted in 4 families, and applications are pending in a number of territories including UK & Europe, PCT, USA, Brazil, Argentina, Australia, China, Hong Kong, India, South Korea, Singapore, Japan, Mexico, and Russia.

Enter your email address to follow ConceptoMed

When you choose to create a user account and follow a newsroom your personal data will be used by us and the owner of the newsroom, for you to receive news and updates according to your subscription settings.

To learn more about this, please read our Privacy Policy, which applies to our use of your personal data, and our Privacy Policy for Contacts, which applies to the use of your personal data by the owner of the newsroom you follow.

Please note that our Terms of Use apply to all use of our services.

You can withdraw your consent at any time by unsubscribing or deleting your account.
Check your inbox

Email sent to __email__. Click the link there to follow ConceptoMed.

Okay